S Ricciardi

Correlation of <i>CDA, ERCC1</i>, and <i>XPD</i> Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

Carmelo Tibaldi, Elisa Giovannetti, Enrico Vasile et al. · Clinical Cancer Research · 2008 · 208 citations

Medicine, Molecular Genetics, Oncology +17

Molecular Mechanisms Underlying the Synergistic Interaction of Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, with the Multitargeted Antifolate Pemetrexed in Non-Small-Cell Lung Cancer Cells

Elisa Giovannetti, Clara Lemos, Christina Tekle et al. · Molecular Pharmacology · 2008 · 159 citations

Medicine, Oncology, Pharmacology +17

Synergistic Antitumor Activity of ZD6474, An Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, with Gemcitabine and Ionizing Radiation against Pancreatic Cancer

Cataldo Bianco, Elisa Giovannetti, Fortunato Ciardiello et al. · Clinical Cancer Research · 2006 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17

Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: Behavioural and biochemical studies

Marco Andrea Riva, N. Brunello, A Rovescalli et al. · 1989 · 57 citations

Medicine, Neuroscience, Pharmacology +15

Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer

Gabriella Ferrandina, Valentina Mey, Sara Nannizzi et al. · Cancer Chemotherapy and Pharmacology · 2009 · 55 citations

Medicine, Molecular Biology, Oncology +16